Semaglutide reduces cardiovascular events by 23% and direct heart disease death risk by 26% compared to dulaglutide in older ...

Researchers report that the weight loss drugs semaglutide and tirzepatide can reduce the risk of hospitalization and death by 40% in people with a common type of heart failure. Experts say this large ...

Sacubitril-valsartan, a common drug combination for heart failure, cuts the risk for cardiomyopathy after chemotherapy in patients who received anthracycline drugs by 77% in the first randomized ...

The U.S. Food and Drug Administration (FDA) has approved Lasix ONYU (furosemide injection), a new drug-device combination developed by SQ Innovation, Inc., for treating edema caused by chronic heart ...

Patient selection should prioritize those with obesity and heart failure with preserved ejection fraction, as benefits for reduced ejection fraction are not yet proven.

Spironolactone, a drug used to manage salt absorption and fluid retention in heart failure patients, also plays a role in inhibiting function of a protein essential to Epstein-Barr virus, a member of ...

Heart failure is a concerning health crisis that is affecting millions of people across the globe. With ongoing effort to ...

Michigan lawmakers plan to save money in the state's Medicaid program by limiting the use of popular weight loss drugs to ...

Doctors are reassessing decades of standard treatment for patients who have had heart attacks after new research shows ...

Generic statins and angiotensin receptor blockers typically used for heart disease also have the potential to bolster the immune systems of patients with Ebola virus and other life-threatening ...